Evidence map

ReviewInflammopharmacology2025

NLRP3 inflammasomes pathway: a key target for Metformin.

Yasamin Hosseini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40042723